Tools
Tools
Yates, M. 
ORCID: https://orcid.org/0000-0003-3977-8920, Saha, P., Aldus, C. ORCID: https://orcid.org/0000-0002-0197-2755, Brown, J. and Macgregor, A. ORCID: https://orcid.org/0000-0003-2163-2325
(2024)
POS0411 Characteristics at diagnosis associated to glucocorticoid use at 2 years for those with polymyalgia rheumatica - A national study of England.
In: UNSPECIFIED.
Abstract
Current guidelines recommend glucocorticoids (GCs) for the treatment of Polymyalgia Rheumatica (PMR) for 1 to 2 years. Surveys and administrative datasets from many European countries and the USA show that approximately 50% of patients are on GCs for at least 2 years. A previous study looking at individuals with PMR and GC dependence, found the neutrophil-lymphocyte ratio (NLR) at diagnosis to be associated with GC dependency.
| Item Type: | Conference or Workshop Item (Paper) |
|---|---|
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Population Health Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Groups > Musculoskeletal Medicine Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 18 Jul 2024 10:30 |
| Last Modified: | 24 Sep 2024 07:26 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/95946 |
| DOI: | 10.1136/annrheumdis-2024-eular.4165 |
Actions (login required)
 |
View Item |